Leonardo Martinez, PhD, MPH
Assistant Professor, Epidemiology - Boston University School of Public Health
Biography
Leo Martinez joined the Department of Epidemiology at Boston University in 2021.
Dr. Martinez uses epidemiological and quantitative approaches to study early-life risk factors for pediatric tuberculosis in high-burden settings, tuberculosis transmission dynamics in high-risk populations (e.g., prisoners, persons living with HIV or diabetes), and the relationship between tuberculosis and non-communicable diseases.
Dr. Martinez's lab is currently working with colleagues and collaborators in several countries globally. We believe that collaboration across professional disciplines, backgrounds, and perspectives is the key to solving intractable health issues and the lab welcomes discussions with others working on these same health issues.
Education
- University of Georgia, PhD
- Tulane University School of Public Health and Tropical Medicine, MPH
- University of Arizona, BA
Classes Taught
- SPHEP764
- SPHEP770
- SPHEP784
Publications
- Published on 11/10/2025
Zhu P, Chen X, Pan J, Wang W, Hao X, Xu B, Zhan B, Fang C, Shen Y, Liu K, Qiu X, Wang W, Chen B, Jiang J, Martínez L. Prognostic value of an abnormal chest X-ray result in predicting the development of tuberculosis. Nat Commun. 2025 Nov 10; 16(1):9866. PMID: 41213917.
Read At: PubMed
- Published on 11/6/2025
Liu Q, Wang W, Nelson K, Wang Z, Khan P, Li Z, Fox MP, Robert Horsburgh C, Brooks M, Zhu L, Wang J, Lu W, Martinez L. Mycobacterium tuberculosis transmission in China during the COVID-19 pandemic period (2020-2021) compared with the pre-pandemic period (2017-2019). Nat Commun. 2025 Nov 06; 16(1):9807. PMID: 41198685.
Read At: PubMed
- Published on 10/27/2025
Saunders MJ, Sinha P, Cegielski JP, Clark RA, Seddon JA, Martinez L, Bhargava M, Bhargava A, White RG, Houben RMGJ, McQuaid CF. Tuberculosis and undernutrition: improving estimates to reinforce the policy imperative. Lancet Infect Dis. 2025 Oct 27. PMID: 41167206.
Read At: PubMed
- Published on 10/16/2025
Ning J, Wang R, Pan Y, Fei X, Jiang W, Martinez L, Zhu L, Qin Z, Liu Q. Impact of tuberculosis on median survival time and years of potential life lost in patients: A scoping review. J Clin Tuberc Other Mycobact Dis. 2025 Dec; 41:100568. PMID: 41146646.
Read At: PubMed
- Published on 10/10/2025
Ge Y, Zahid A, Kuchur R, Martinez L, Wang B, Zhang L, Aras S, Raynee P, Dike A, Navarro C, Lawrick C, Greer T, Twum F, Shen Y, Gipson J, Lemacks J. Using machine learning models to predict vaccine hesitancy: a showcase of COVID-19 vaccine hesitancy in rural populations during the pandemic. Vaccine. 2025 Oct 10; 66:127799. PMID: 41075400.
Read At: PubMed
- Published on 9/23/2025
Martinez L, Campbell JI, Linde L, Boulahbal F, Cayla JA, Chakhaia T, Chan PC, Chen C, Fang CT, Fox G, Grandjean L, Hannoun D, Hesseling A, Horsburgh CR, Huang LM, Liu Q, Mazahir R, Lee CH, Lee LN, Bennet R, Nejat S, Gupta A, Das M, Murray M, Huang CC, Del Corral H, Benjumea-Bedoya D, Shen Y, Becerra M, Chang V, Krishnan S, Heinmueller P, Brewer T, Isaakidis P, Hauri AM, Shah L, Trieu L, Seddon JA. The Effectiveness of Isoniazid Preventive Treatment among Contacts of Multidrug-Resistant Tuberculosis: A Systematic Review and Individual-Participant Meta-Analysis. Am J Respir Crit Care Med. 2025 Sep 23. PMID: 40986702.
Read At: PubMed
- Published on 9/17/2025
Fei X, Wang S, Wang Z, Hu X, Chen C, Zhu L, Martinez L, Tang P, Liu Q. Diagnostic accuracy of the ESAT6-CFP10 skin test for latent tuberculosis infection among jail detainees. Microbiol Spectr. 2025 Oct 07; 13(10):e0150025. PMID: 40960282.
Read At: PubMed
- Published on 9/12/2025
Menzies NA, Brown TS, Imai-Eaton JW, Dodd PJ, Cohen T, Martinez L. Potential paediatric tuberculosis incidence and deaths resulting from interruption in programmes supported by international health aid, 2025-34: a mathematical modelling study. Lancet Child Adolesc Health. 2025 Nov; 9(11):787-795. PMID: 40953585.
Read At: PubMed
- Published on 8/29/2025
Malik AA, Martinez L. Achieving optimal uptake of TB preventive treatment for rifampin-resistant and/or multidrug-resistant TB. Int J Tuberc Lung Dis. 2025 Aug 29; 29(9):387-389. PMID: 40883889.
Read At: PubMed
- Published on 8/8/2025
Seddon JA, Martinez L. Patient-centred approaches for drug-resistant tuberculosis - Authors' reply. Lancet Infect Dis. 2025 Oct; 25(10):e543. PMID: 40789302.
Read At: PubMed
View 144 more publications:View Full Profile at BUMC
News & In the Media
-
Published on October 17, 2025
US Funding Cuts Could Result in Nearly 9 Million Child Tuberculosis Cases, 1.5 Million Child Deaths
-
Published on September 19, 2025
Certificate Spotlight: Infectious Disease with Anushka Reddy Marri (SPH’24)
-
Published on August 29, 2025
Standard Tests Alone Not Sufficient to Predict Tuberculosis in Immunocompromised Individuals
-
Published on August 18, 2025
Tuberculosis Spawning in Crowded, Dirty ICE Detention Centers
-
Published on March 31, 2025
Many TB Cases May Have Gone Undetected in Prisons in Europe and the Americas During COVID-19
- Published on March 14, 2025
-
Published on November 8, 2024
10% of Children in High-Burden Tuberculosis Settings May Develop the Disease by Age 10
-
Published on May 13, 2024
Risk-Targeted Preventive TB Treatment Works, Particularly with Infection Testing
- Published on May 9, 2024
-
Published on July 14, 2023
Tuberculosis in Prisons Goes Undetected at Alarming Rates, Global Data Show
-
Published on July 11, 2023
Thousands of IIOJK Detainees Could Suffer as Prisoners in India at 5 Times More TB Risk: Study
- Published on July 6, 2023
- Published on July 1, 2023
-
Published on June 29, 2023
Nearly Half of Tuberculosis Cases in Prisons Worldwide Go Undetected
-
Published on April 14, 2023
Pediatric TB May Affect Lung Functioning, Growth Later in Life
-
Published on August 12, 2022
BCG Vaccine Prevents TB in Young Children, but Not Adults – New Study
-
Published on August 9, 2022
BCG Vaccine Prevents Tuberculosis in Young Children, but Not Adults
- Published on January 19, 2022
-
Published on January 19, 2022
Expect More Worrisome Variants after Omicron, Scientists Say
-
Published on January 3, 2022
CDC Study Says Omicron Variant’s Incubation Period Is about 3 Days—Here’s What That Means
-
Published on November 18, 2021
Children with Cytomegalovirus Infection by Age One More Likely to Develop Tuberculosis in Childhood
-
Published on November 17, 2021
Children with Cytomegalovirus Infection by Age 1 More Likely to Develop Tuberculosis in Childhood
- Published on August 30, 2021
- Published on August 30, 2021
-
Published on August 23, 2021
COVID-19 Is Most Transmissible 2 Days Before, 3 Days After Symptoms Appear
- Published on April 9, 2021